Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …

Approximately half of the patients with signs and symptoms of heart failure have a left
ventricular ejection fraction that is not markedly abnormal. Despite the historically initial …

Abstract Aims Cardiac microRNA-132-3p (miR-132) levels are increased in patients with
heart failure (HF) and mechanistically drive cardiac remodelling processes. CDR132L, a …

Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …

Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of
the large number of genes and alleles attributed to DCM, comprehensive genetic testing …

Aims Transthyretin cardiac amyloidosis (ATTR-CA) has been reported in patients with aortic
stenosis (AS) but its prevalence and phenotype are not known. We examine elderly patients …

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, including empagliflozin, dapagliflozin,
and canagliflozin, are now widely approved antihyperglycemic therapies. Because of their …

Aims Coronary microvascular ischaemia, cardiomyocyte injury and stiffness may play an
important role in the pathophysiology of heart failure with preserved ejection fraction …